United Kingdom - English - myHealthbox

brown & burk uk ltd - irbesartan - film-coated tablets - 300mg - angiotensin-ii antagonists, plain - it is indicated in adults for the treatment of essential hypertension. it is also indicated for the treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen

European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - irbesartan - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.treatment of renal disease in patients with hypertension and type-2 diabetes mellitus as part of an antihypertensive medicinal-product regimen.

European Union - English - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - irbesartan - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.treatment of renal disease in patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen (see section 5.1).

European Union - English - EMA (European Medicines Agency)

teva b.v. - irbesartan - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.treatment of renal disease in patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen.

European Union - English - EMA (European Medicines Agency)

zentiva k.s. - irbesartan - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.treatment of renal disease in patients with hypertension and type-2 diabetes mellitus as part of an antihypertensive medicinal-product regimen.

European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - irbesartan - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.treatment of renal disease in patients with hypertension and type-2 diabetes mellitus as part of an antihypertensive medicinal product regimen.

European Union - English - EMA (European Medicines Agency)

pharmathen s.a. - irbesartan - hypertension - agents acting on the renin-angiotensin system - sabervel is indicated in adults for the treatment of essential hypertension.it is also indicated for the treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen.

Canada - English - Health Canada

sanofi-aventis canada inc - irbesartan - tablet - 75mg - irbesartan 75mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

sanofi-aventis canada inc - irbesartan - tablet - 150mg - irbesartan 150mg - angiotensin ii receptor antagonists

Canada - English - Health Canada

sanofi-aventis canada inc - irbesartan - tablet - 300mg - irbesartan 300mg - angiotensin ii receptor antagonists